Cannabis Campaigners' Guide News Database result:


After you have finished reading this article you can click here to go back.

UK: William Ransom seeks cannabis boost

James Rossiter

London Evening Standard

Monday 27 Jun 2005

---

NATURAL healthcare company William Ransom is working on producing a
cannabis-extract for migraine and rheumatoid arthritis.

The AIM-listed firm is better known for over-the-counter products, ranging
from aloe vera-based toothpastes and Radian B muscle rub to Manuca honey,
but a move into producing marijuana resins would not be a first for the firm.

Hitchin-based Ransom used to produce extracts of the infamous weed more
than 30 years ago, its chief executive Tim Dye told the Evening Standard,
until changes to the law prohibited its prescription as a medicine in 1973.

Now a EU1.3m (ukp862,000) grant from the EU to a consortium spearheaded by
Ransom has triggered a two-year project to examine if there is a viable
market for use in medical therapies.

Earlier this month, GW Pharmaceuticals lost an appeal with UK regulators to
allow it to market its cannabis-derived painkiller Sativex for multiple
sclerosis sufferers.

Dye said he is working closely with the University of London School of
Pharmacy on his project. A further five Continental academic institutions
and two small research firms are involved.

He is also taking advice from former chairman Michael Ransom, a by the
appointment as a director-of former Olympic swimming champion David Wilkie.
Ransom bought his food supplements business a year ago.

 

 

 

After you have finished reading this article you can click here to go back. 




This page was created by the Cannabis Campaigners' Guide.

Feel free to link to this page!